Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:

  • gov.je

    Update your notification preferences

  • one.gov.je

    Access government services

  • CAESAR

    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Prescribed List: Changes from 1 April 2018

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

  • demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision

  • providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made 2 March 2018:

Decision Reference: MD-S-2018-0016

Decision Summary Title :

Changes to Prescribed List as of 1 April 2018

Date of Decision Summary:

26 February 2018

Decision Summary Author:

Policy Principal

Decision Summary:

Public or Exempt?

Public

Type of Report:

Oral or Written?

Written

Person Giving

Oral Report:

N/A

Written Report

Title :

Changes to be made to the Prescribed List as of 1 April 2018

Date of Written Report:

26 February 2018

Written Report Author:

Policy Principal

Written Report :

Public or Exempt?

Public

Subject:  Changes to be made to the Prescribed List (Jersey) as at 1 April 2018

Decision(s): Further to Article 15, paragraphs (11) and (12), of the Health Insurance (Jersey) Law 1967, and having consulted with the Pharmaceutical Benefit Advisory Committee, the Minister decided to make amendments to the Prescribed List with effect from 1 April 2018.

Reason(s) for Decision:

The Pharmaceutical Benefit Advisory Committee met on 22 February 2018 and has provided the Minister with the accompanying written report setting out its recommendations in respect of amendments to the Prescribed List.

 

Additional preparations of product already listed 

Estradiol hemihydrate (Estring) 7.5micrograms/24hours vaginal delivery system for the local treatment of urogenital symptoms of the menopause.

 

 

Other amendments

Aripiprazole tablet is recommended for reimbursement as generic product only

Midazolam oromuscosal (buccal) solution entry to be amended to include the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents.

Oseltamivir oral suspension entry to be amended to oseltamivir oral solution SF 15mg/mL and oral suspension 6mg/mL

Resource Implications:  The impact of these changes is expected to be cost neutral

 

Action required:

Business Manager to issue public notice listing amendments and notify all approved medical practitioners and approved contractors.

 

Signature:

Position:

Minister

Date Signed:

 

Date of Decision (If different from Date Signed):

 

Back to top
rating button